ACHE and cystic fibrosis: The AChE activity was significantly decreased in CF-treated groups (100 and 200 mg/kg) when compared to the SCO group (p  <  0.01).CF-2 (12.5 and 25 mg/kg) significantly reduced AChE activity at both doses (p  <  0.01) in comparison to the SCO group.